Tradestie Institutional Equity Comparison Engine

BIAF vs SHPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SHPH Overall Edge

SHPH Captures Institutional Edge (2โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BIAF trades at N/M Forward P/E with -246.1% operating margin (-26.0% YoY revenue) versus SHPH at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BIAF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SHPH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BIAF N/M vs SHPH N/M Fwd P/E
Growth & Margin Winner SHPH
Op Margin -246.1% vs 0.0% ยท YoY -26.0% vs +0.0%
Momentum & Technical Winner SHPH
1Y +12.2% vs +76.3% ยท 52W Pos 7% vs 54%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BIAF NASDAQ
bioAffinity Technologies, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.65
-10.81% 1D
Market Cap $3.3M
1M Return -47.95%
1Y Return +12.24%
Forward P/E N/M
Unified AI Score
48.0 / 100 HOLD
Tech 38.0 Fund 51.0 Flow 50.0 Mom 64.0
SHPH NASDAQ
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Pharmaceutical Preparations
$3.49
-10.51% 1D
Market Cap $17.6M
1M Return -24.3%
1Y Return +76.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIAF +12.24% SHPH +76.26% Spread: +64.02 pp (SHPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIAF TTM Op. Margin: -246.1% SHPH TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIAF vs SHPH. Trailing 12-month operating profitability (BIAF -246.1% vs SHPH 0.0%) and valuation multiples (BIAF N/M vs SHPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIAF (0) vs SHPH (8)
Institutional Metric BIAF SHPH Criterion Row Winner
Market Capitalization Scale $3.3M $17.6M Larger Scale SHPH
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -26.0% +0.0% Higher Growth SHPH
Operating Margin (TTM) Profitability -246.1% 0.0% Higher Margin SHPH
Net Profit Margin Profitability -278.9% 0.0% Higher Margin SHPH
Return on Equity (ROE) Capital Efficiency -240.5% -90.0% Higher ROE SHPH
52-Week Range Position Momentum 7% ($0โ€“$20) 54% ($0โ€“$6) Stronger Trend SHPH
Beta / 30D Volatility Risk Regime -0.62ฮฒ ยท 120% Vol 9.23ฮฒ ยท 88% Vol Lower Realized Risk SHPH
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite SHPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIAF vs SHPH Buy Guide
BIAF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BIAF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SHPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SHPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIAF nor SHPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.